For the Inventor, By the Inventor

Enter assignee name

Montreal, Canada

Conjuchem, Inc.

USPTO Granted Patents = 28

Forward Citations = 1,258

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Dominique P Bridon (17 out of 26 patents)

Alan M Ezrin (16 out of 18 patents)

Darren L Holmes (14 out of 16 patents)

4. Peter G Milner (9 out of 41 patents)

5. Benoit L'Archeveque (8 out of 8 patents)

6. Anouk Leblanc (8 out of 8 patents)

7. Serge St Pierre (8 out of 9 patents)

8. Karen Thibaudeau (7 out of 13 patents)

9. Alexander Krantz (5 out of 27 patents)

10. Dominique Bridon (4 out of 13 patents)

11. Yonghong Song (3 out of 61 patents)

12. Martin Robitaille (3 out of 14 patents)

13. Nissab Boudjellab (3 out of 6 patents)

14. Wolin Huang (2 out of 26 patents)

15. Arthur M Hanel (2 out of 3 patents)

28 patents: Sort by Forward Citations

1. 8093206 - Methods involving long lasting synthetic exendin-4 peptide conjugates (2012-01-10),

2. 8084414 - Methods involving long lasting synthetic exendin-4-peptide conjugates (2011-12-27),

3. 8080516 - Long lasting synthetic exendin-4 peptide conjugates (2011-12-20),

4. 8039432 - Method of treatment of diabetes and/or obesity with reduced nausea side effect (2011-10-18),

5. 7982018 - Modified corticotropin releasing factor peptides and uses thereof (2011-07-19),

6. 7144854 - Long lasting anti-angiogenic peptides (2006-12-05),

7. 7112567 - Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders (2006-09-26),

8. 7090851 - Long lasting fusion peptide inhibitors of viral infection (2006-08-15),

9. 6887849 - Long lasting synthetic glucagon-like peptide {GLP-1} (2005-05-03),

10. 6887470 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2005-05-03),

11. 6849714 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2005-02-01),

12. 6821949 - Long lasting synthetic glucagon-like peptide (GLP-1) (2004-11-23),

13. 6706892 - Pulmonary delivery for bioconjugation (2004-03-16),

14. 6610825 - Method for alleviating pain or providing an analgesic effect in a patient (2003-08-26),

15. 6602981 - Antinociceptive agent derivative (2003-08-05),

ConjuChem, Inc. is a biotechnology company focused on the development of innovative therapeutics. With a strong emphasis on drug conjugate technology, ConjuChem aims to revolutionize the treatment of various diseases, including cancer and metabolic disorders. Through its cutting-edge research and development efforts, the company strives to provide patients with more effective and targeted treatment options. Visit their website to learn more about their groundbreaking work.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

28 Patents

#34 in Montreal

#473 in Canada

#22,565 in the World

Montreal, Canada

Conjuchem, Inc.

Forward Citations = 1,258

30 inventors:

Dominique P Bridon (17 out of 26 patents)

Alan M Ezrin (16 out of 18 patents)

Darren L Holmes (14 out of 16 patents)

4. Peter G Milner (9 out of 41 patents)

5. Benoit L'Archeveque (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…